These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17054419)

  • 41. Genomics and Metabolomics in Obesity and Type 2 Diabetes.
    Kretowski A; Ruperez FJ; Ciborowski M
    J Diabetes Res; 2016; 2016():9415645. PubMed ID: 27314051
    [No Abstract]   [Full Text] [Related]  

  • 42. Applications of metabolomics to understanding obesity in mouse and man.
    Gulston MK; Titman CM; Griffin JL
    Biomark Med; 2007 Dec; 1(4):575-82. PubMed ID: 20477375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomic strategies to study lipotoxicity in cardiovascular disease.
    Waterman CL; Kian-Kai C; Griffin JL
    Biochim Biophys Acta; 2010 Mar; 1801(3):230-4. PubMed ID: 19944186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?
    van der Greef J; Hankemeier T; McBurney RN
    Pharmacogenomics; 2006 Oct; 7(7):1087-94. PubMed ID: 17054418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drosophila gains traction as a repurposed tool to investigate metabolism.
    Padmanabha D; Baker KD
    Trends Endocrinol Metab; 2014 Oct; 25(10):518-27. PubMed ID: 24768030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiplex Biomarker Approaches in Type 2 Diabetes Mellitus Research.
    Ozanne SE; Rahmoune H; Guest PC
    Methods Mol Biol; 2017; 1546():37-55. PubMed ID: 27896756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional annotation of genomic data with metabolic inference.
    Walzem RL; Baillie RA; Wiest M; Davis R; Watkins SM; Porter TE; Simon J; Cogburn LA
    Poult Sci; 2007 Jul; 86(7):1510-22. PubMed ID: 17575202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolomics and Metabolic Diseases: Where Do We Stand?
    Newgard CB
    Cell Metab; 2017 Jan; 25(1):43-56. PubMed ID: 28094011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk?
    Aronis KN; Kim YB; Mantzoros CS
    Metabolism; 2011 Jun; 60(6):747-8. PubMed ID: 21333309
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.
    Shah SH; Kraus WE; Newgard CB
    Circulation; 2012 Aug; 126(9):1110-20. PubMed ID: 22927473
    [No Abstract]   [Full Text] [Related]  

  • 51. Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk.
    Regan JA; Shah SH
    Curr Cardiol Rep; 2020 Oct; 22(12):174. PubMed ID: 33040225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating potential mechanisms of obesity by metabolomics.
    Xie B; Waters MJ; Schirra HJ
    J Biomed Biotechnol; 2012; 2012():805683. PubMed ID: 22665992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 'Omic' approaches and lipid metabolism: are these new technologies holding their promises?
    Mooser V; Ordovas JM
    Curr Opin Lipidol; 2003 Apr; 14(2):115-9. PubMed ID: 12642778
    [No Abstract]   [Full Text] [Related]  

  • 54. Overview of genomics and post-genomics research on type 2 diabetes mellitus: Future perspectives and a framework for further studies.
    Reddy BM; Pranavchand R; Latheef SAA
    J Biosci; 2019 Mar; 44(1):. PubMed ID: 30837372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity. A new paradigm for treating obesity and diabetes mellitus.
    Scheen AJ; Paquot N
    Nat Rev Endocrinol; 2015 Apr; 11(4):196-8. PubMed ID: 25623121
    [No Abstract]   [Full Text] [Related]  

  • 56. Hijacking of Endocrine and Metabolic Regulation in Cancer and Diabetes.
    McGowan EM; Simpson A; McManaman J; Boonyaratanakornkit V; Hardikar AA
    Biomed Res Int; 2015; 2015():386203. PubMed ID: 26240821
    [No Abstract]   [Full Text] [Related]  

  • 57. Metabolomics and individual metabolic assessment: the next great challenge for nutrition.
    German JB; Roberts MA; Fay L; Watkins SM
    J Nutr; 2002 Sep; 132(9):2486-7. PubMed ID: 12221197
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular approaches in obesity studies.
    Zamanian-Azodi M; Vafaee R; Azodi T; Omidi R; Gilanchi S; Azizi-Jalilian F; Khodarahmi R
    Gastroenterol Hepatol Bed Bench; 2013; 6(Suppl 1):S23-31. PubMed ID: 24834284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A big circuit model.
    Hood E
    Environ Health Perspect; 2003 Aug; 111(11):A576-7. PubMed ID: 12940284
    [No Abstract]   [Full Text] [Related]  

  • 60. [INEQUALITY IN RELATION TO OBESITY. (ANALYTICAL REVIEW)].
    KLOTZ HP; ELMALEH H
    Probl Actuels Endocrinol Nutr; 1963; 7():7-21. PubMed ID: 14166759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.